Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for ...

Automated insulin delivery (AID) systems reduce diabetes distress and fear of hypoglycemia, improve quality of life, and increase awareness about hypoglycemia in adults, children, and adolescents ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

She added, "We hope these case studies provide insights for health care professionals who assist athletes with type 1 diabetes using automated insulin delivery systems during intense physical ...

This growth will be mostly driven by insulin delivery devices ... MiniMed 600 series and 700 series pump systems. "Luna Diabetes trials automated wearable insulin pump" was originally created ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Medtech companies have been working to create an automated insulin delivery system that requires minimal action from patients - and these integrations put both firms one step closer to this goal.

Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.

Medscape Medical News, October 16, 2024 Automated Insulin Delivery Systems Reduce Burden in Diabetes Automated insulin delivery systems not only improved glycemic endpoints but also alleviated ...

SAN DIEGO, CA / ACCESSWIRE / October 23, 2024 / Luna Diabetes announces the start of its pivotal trial for the Luna System today. Luna is the first automated insulin delivery solution intended for ...

Insulet ( (PODD) ) has released its Q3 earnings. Here is a breakdown of the information Insulet presented to its investors. Insulet ...